Welcome : Guest

CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM) Devices in US$ Million by the following Product Segments: Implantable Cardioverter Defibrillators (ICD), Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) devices. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 48 companies including many key and niche players such as -

Bard Electrophysiology
Biosense Webster, Inc.
Biotronik GMBH & Co. KG
Boston Scientific Corporation
Medtronic, Inc.
Medtronic CryoCath LP

Click here to request a full list of companies covered in the report...

Code: MCP-6132
Price: $4500
Companies: 48
Pages: 367
Date: October 2011
Market Data Tables: 81
 



TABLE OF CONTENTS


  CARDIAC RHYTHM MANAGEMENT (CRM) DEVICES (Complete Report) Pages : 367   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Implantable Cardioverter Defibrillators (ICD).....I-3
  
   Pacemaker.....I-4
External Defibrillators.....I-4
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....I-4
  
   A Prelude.....II-5
Cardiac Rhythm Management Devices - An Outlook.....II-5
Implantable Cardioverter Defibrillators.....II-5
1$100
   Pacemakers.....II-6
External Defibrillators.....II-6
EP Catheterization, Mapping, & Ablation (CMA).....II-6
Market Structure.....II-6
1$100
   Table 1: World Market for Cardiac Rhythm Management (CRM) Devices (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-7

Table 2: World Market for High Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies. (includes corresponding Graph/Chart).....II-7

Table 3: World Market for Low Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies(includes corresponding Graph/Chart).....II-7
1$350
   Table 4: World Market for ImplanTable Cardioverter Defibrillator (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-8

Table 5: World External Defibrillators Market (2010): Percentage Market Share Breakdown of Leading Players - Medtronic, Philips and Others (includes corresponding Graph/Chart) (includes corresponding Graph/Chart).....II-8

Table 6: World Market for Advanced Cardiac Resynchronization Therapy (CRT) Devices (2010): Percentage Market Share Breakdown of Leading Players - Medtronic, Boston Scientific (Guidant), St. Jude Medical, and Others (includes corresponding Graph/Chart).....II-8
1$350
   SSS and AV Block Incidence Triggers Demand for Pacemakers .....II-9
Infamous Product Recalls Throw Growth Off-track.....II-9
Market Shapes Up After the Recall Shock.....II-9
1$100
   Regulatory Riders Knit to Ensure Greater Device Reliability.....II-10
Growing Proportion of Obese Population: A Major Demographic Driver.....II-10
Replacements to Drive the Growth of ICDs.....II-10
1$100
   Developments in Energy-Based Therapies Augur Well for Cardiac Ablation
  Treatments.....II-11
Expanding Applications Lend Traction to Growth.....II-11
1$100
   Prices of Cardiac Pacemakers Soften.....II-12
Heart Patients Using ICD, Enjoy Satisfactory Quality Life.....II-12
Pacemakers Ensure Effective Management of Non-Systolic Heart Failures.....II-12
1$100
   CRT: An Effective Treatment for Bradycardia, Tachycardia & Fibrillation.....II-13
ICDs in Pediatric Care Shows Promise.....II-13
Emerging Therapies for the Treatment of Atrial Fibrillation.....II-13
1$100
   New Generation CRM Devices Feature Superior Benefits.....II-14
MRI-Compatible Pacemakers & ICDs.....II-14
1$100
   Resistance Against Electronic Interferences.....II-15
Confusion Over the Use of CRM Devices Threaten Perceived Effectiveness.....II-15
1$100
   Breathing Disorders in Patients Implanted with Pacemakers: A Cause for Concern.....II-16
Approval of Untested Pacemaker Connectors Raises Eyebrows.....II-16
1$100
   ICD Lead Failure Demands Immediate Attention.....II-17
Pacemaker Hacking Has the Industry Up by Its Ears.....II-17
Pacemakers Face Stiff Competition from CRT-D Devices.....II-17
1$100
   ICDs More Prone to Malfunction than Pacemakers.....II-18
Conclusion.....II-18
Technology Innovation: A Futuristic Rumination.....II-18
The Heart to Power CRM Devices: The Future of CRM Therapies.....II-18
1$100
   Genetic Advances to Yield Replacement for Pacemakers.....II-19
Ablation Technology Undergoing Innovations.....II-19
Vein Ablation Catheter Proves Successful in Cases of Paroxysmal Atrial
  Fibrillation.....II-19
1$100
   Ablation Therapy Useful in Treating Persistent/ Permanent Atrial Fibrillation
  (PPAF).....II-20
Magnetic Navigation: An Innovation in Catheter Ablation.....II-20
New Force-Sensing Ablation Catheter Aims to Aid Physician Decision Making.....II-20
1$100
   Pricing & Reimbursements: Critical Determinants of Growth.....II-21
New Guidelines Issued for Safe Management of CRM Devices in the US and Europe.....II-21
2$125
   Sudden Cardiac Arrest: A Leading Cause of Death.....II-23
Cardiac Rhythm Management (CRM): A Definition.....II-23
Implantable Cardioverter Defibrillators (ICDs).....II-23
1$100
   Surgical Implantation of ICDs: The Procedure.....II-24
ICDs – The Benefits.....II-24
Types of ICDs.....II-24
1$100
   ICDs: An Evolution Scan.....II-25
Complications Associated With ICD Usage.....II-25
CRT-D – A New Therapeutic Device.....II-25
Pacemakers.....II-25
1$100
   Surgical Implantation of Pacemakers: The Procedure.....II-26
Types of Pacemakers.....II-26
Methods of Pacing.....II-26
Fixed Rate Pacemakers.....II-26
1$100
   Demand Pacemakers.....II-27
Rate-Responsive Pacemaker.....II-27
Pacemakers: An Evolution Scan.....II-27
Complications Associated with Pacemakers.....II-27
1$100
   Advent of CRT-P.....II-28
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....II-28
The Ablation Procedure.....II-28
1$100
   External Defibrillators.....II-29
Types of AEDs.....II-29
1$100
   Cardiac Rhythm Disorders: A Brief Review.....II-30
Cardiac Arrhythmias.....II-30
Classification of Cardiac Arrhythmias.....II-30
1$100
   Bradycardia.....II-31
Tachycardia.....II-31
Atrial Fibrillation.....II-31
1$100
   Heart Blocks.....II-32
Syncope.....II-32
Sick Sinus Syndrome.....II-32
1$100
   Cardiomyopathy.....II-331$100
   Boston Scientific Unveils CRM Connector System.....II-34
Biosense Catheter Receives FDA Marketing Approval.....II-34
St. Jude Medical Secures Approval for Atlas II ICD from Japan.....II-34
Zoll Medical Defibrillators Receive FDA Clearance.....II-34
1$100
   St. Jude Medical Receives CE Mark for Integrated Irrigation Pump and Ablation
  Generator.....II-35
AtriCure Secures FDA 510(k) Approval for Coolrail Device.....II-35
Hansen Medical Gains FDA Approval for CoHesion™ Module.....II-35
1$100
   St. Jude Medical Obtains CE Mark and FDA Approval for HIFU Surgical Ablation
  Solutions.....II-36
Biosense Releases NAVISTAR® RMT THERMOCOOL® Catheter.....II-36
1$100
   Atricure Unveils The ORLab™.....II-37
Cardima Receives SFDA Approval to Market INTELLITEMP® in China.....II-37
ZOLL Obtains 510K Clearance to Sell and Market Zoll R Series Code-Ready
  Defibrillator.....II-37
1$100
   ST. Jude Medical Obtains FDA and CE Mark Approval for New Epicor LP Cardiac Ablation
  System.....II-38
Cardima Obtains Approval for Marketing Surgical Ablation System in Thailand.....II-38
ATS Medical Introduces First CryoMaze Surgical Ablation Clamp.....II-38
CardioNet Unveils New Reporting Package for Atrial Fibrillation Treatment.....II-38
1$100
   Boston Scientific Defibrillator Receives CE Mark Approval.....II-39
TyRx Introduces New Anti-bacterial Envelope, AIGISRX™ ICD.....II-39
St. Jude Medical Receives Approval from Japanese MHLW.....II-39
1$100
   Boston Scientific Secures FDA Approval for CRM Solutions.....II-40
Sorin Group Develops New-Generation CRT-D Implants.....II-40
BSC Secures CE Mark Approval for ALTRUA Pacemakers.....II-40
1$100
   Medtronic Secures FDA Approval for New Vision 3D Devices.....II-41
Medtronic Obtains FDA Approval for Software Update.....II-41
St. Jude Medical Obtains FDA Approval for SJM Cardiac Monitor.....II-41
1$100
   Boston Scientific Obtains Approval For Cognis CRT-D And Teligen ICD.....II-42
FDA Approves Medtronic’s Medtronic Sprint Quattro Secure® S Lead.....II-42
Medtronic Obtains CE Mark Approval for Pacemaker and Pacing Leads.....II-42
St. Jude Medical Obtains Japanese Approval for Victory® Pacemakers Family.....II-42
1$100
   Sorin Group Obtains Approval For Isoline Defibrillation Leads In Japan.....II-43
BSC Secures FDA Approval for New ALTRUA Pacemakers.....II-43
1$100
   St. Jude Medical Obtains Approval for Durata Defibrillation Lead.....II-44
St. Jude Medical Obtains Japanese Approval for Durata Defibrillation Lead.....II-44
St. Jude Medical Obtains Japanese Approval for Victory Family of Pacemakers.....II-44
1$100
   Sorin Group Gains FDA Approval for OVATIO™.....II-45
Sorin SpA Gains FDA Approval for REPLY.....II-45
Medtronic Receives Approval for Lead Integrity Alert™.....II-45
Physio-Control Gains FDA Approval for LIFEPAK® 20e Defibrillator/Monitor.....II-45
1$100
   TyRx Introduces New Anti-Bacterial Envelope, AIGISRX™ ICD.....II-46
LifeWatch Introduces Next-Generation Monitor, LifeStar ACT III Platinum.....II-46
eCardio Launches eVolution, New Cardiac Monitoring System.....II-46
1$100
   Philips Introduces PageWriter TC70 Cardiograph.....II-47
Sorin Group Announces Commercial Release and First Implant of PARADYM™ CRT
  8750.....II-47
St. Jude Medical Introduces QuickOpt® Timing Cycle Optimization in CRT-D.....II-47
1$100
   Cardiac Science Unveils Simple Electronic Reporting System.....II-48
Mennen Medical Introduces VitaLogik® 4000 Line.....II-48
1$100
   BIOTRONIK Releases CRT-P in US Market.....II-49
Vermed Releases Defibrillation Pads Series and Universal Connector System.....II-49
St. Jude Releases Reflexion Spiral X™ in US.....II-49
1$100
   Novation Partners St. Jude Medical for CRM Products.....II-50
Medtronic Sets Up Production Unit in Singapore.....II-50
Novation Collaborates with BIOTRONIK.....II-50
Boston Scientific Inks Agreement with Fukuda Denshi.....II-50
1$100
   Creganna Closes Tactx Medical Acquisition.....II-51
Medtronic Takes Over Ablation Frontiers.....II-51
Sorin Enters into Agreement with Orange Business Services.....II-51
1$100
   Philips Signs a Deal with Bard Electrophysiology.....II-52
Boston Scientific Bags CRM Contract from Dept. of Veterans Affairs.....II-52
Medtronic and Boston Scientific Inks Agreement to End IP Disputes.....II-52
1$100
   St Jude Medical to Invest in Penang.....II-53
Cardima Enters into a Distribution Agreement with Peerless Medical.....II-53
Cardiac Science Enters into an Alliance with Boy Scouts of America.....II-53
1$100
   Cardima Enters into a New Strategic Surgical Alliance with Biocore.....II-54
Cardima Enters into a New Strategic Marketing Alliance with On-X Life
  Technologies.....II-54
Welch Allyn and ZOLL Medical Corporation Collaborate.....II-54
1$100
   Cardima Selects Dot Medical to Distribute Its EP Products in the UK.....II-55
Royal Philips to Guide ‘euHeart’ Project.....II-55
Target Center Acquires HeartSine® Defibrillators.....II-55
1$100
   St Jude Medical Acquires EP MedSystems.....II-56
St. Jude Takes Over Radi Medical AB.....II-56
Medrad to Acquire Possis.....II-56
Phoenix Acquires Stake in Possis.....II-56
1$100
   Biotronik Acquires VascoMed.....II-57
Medtronic Takes Over CryoCath Technologies.....II-57
Boston Scientific Takes Over CryoCor.....II-57
St. Jude Completes Acquisition of MediGuide.....II-57
1$100
   Greatbatch Enters Into A Strategic Partnership With Issys.....II-58
Sorin Group Inks Collaborative Agreement with Greatbatch.....II-58
Philips Enters into MOU with King’s College London on Research Collaboration.....II-58
1$100
   Welch Allyn Collaborates with ZOLL Medical Corporation.....II-59
ZOLL and HealthTrust Sign Purchasing Deal.....II-59
ZOLL Inks Multi-Year Agreement with Masimo.....II-59
First Responder Wins Contract from Harvard School of Public Health.....II-59
1$100
   Beijing Airport Group to Deploy ZOLL AED Plus Solutions.....II-60
STH NHS Trust to Deploy New R Series BLS Solutions of ZOLL.....II-60
Major EMS Centers in China Deploys ZOLL M Series Defibrillator.....II-60
1$100
   DRF to Deploy corpuls3 Heart Defibrillators.....II-61
Riedel & Schulz and GS Elektromed Distributes 8 corpuls3 Medical Units.....II-61
Trivitron Inks Marketing And Distribution Agreement With Boston Scientific.....II-61
CardioComm Signs Licensing Agreement with GE Healthcare.....II-61
Cambridge Heart Licenses Technology for Implantable Devices.....II-61
1$100
   Synovis Life Technologies to Divest Interventional Business.....II-62
Boston Scientific Divests Cardiac Surgery And Vascular Surgery Businesses.....II-62
Sorin Group Sells Its Vascular Therapy Business to CIDl.....II-62
1$100
   Bard Electrophysiology (US).....II-63
Biosense Webster, Inc. (US).....II-63
Biotronik GMBH & Co. KG (Germany).....II-63
Boston Scientific Corporation (US).....II-63
1$100
   Medtronic, Inc. (US).....II-64
Medtronic CryoCath LP (US).....II-64
Vitatron Nederland BV (Netherlands).....II-64
1$100
   Philips Healthcare (The Netherlands).....II-65
St. Jude Medical, Inc. (US).....II-65
Sorin Group (Italy).....II-65
1$100
   Table 7: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-661$350
   Table 8: World Historic Review for Cardiac Rhythm Management Devices by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-671$350
   Table 9: World 15-Year Perspective for Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-681$350
   Table 10: World Recent Past, Current & Future Analysis for ImplanTable Cardioverter Defibrillators by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-691$350
   Table 11: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-701$350
   Table 12: World 15-Year Perspective for ImplanTable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-711$350
   Table 13: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-721$350
   Table 14: World Historic Review for Pacemakers by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-731$350
   Table 15: World 15-Year Perspective for Pacemakers by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-741$350
   Table 16: World Recent Past, Current & Future Analysis for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-751$350
   Table 17: World Historic Review for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-761$350
   Table 18: World 15-Year Perspective for External Defibrillators by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-771$350
   Table 19: World Recent Past, Current & Future Analysis for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-781$350
   Table 20: World Historic Review for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-791$350
   Table 21: World 15-Year Perspective for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-801$350
   A. Market Analysis.....II-81
Outlook.....II-81
Market Overview.....II-81
Demand for Automated External Defibrillators Shoots Up in the US.....II-81
1$100
   Market Share Statistics.....II-82
Table 22: US Market for (ICD) Implantable Cardioverter Defibrillators (2011): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-82

Table 23: US Market for Core Pacemakers & CRT-P (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-82
Cardiovascular Disease Incidence Statistics.....II-82
Table 24: Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Disease Type (includes corresponding Graph/Chart).....II-82
1$350
   Table 25: Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Type of Expenditure (includes corresponding Graph/Chart).....II-83

Table 26: Cardiovascular Diseases (CvD) in US (2010): Incidence of CvDs in Adult Population Segregated by Age and Gender (includes corresponding Graph/Chart).....II-83
1$350
   Table 27: Cardiovascular Diseases (CvD) in the US (2010): Percentage Breakdown of Deaths by Type of Causal CvD (includes corresponding Graph/Chart).....II-841$350
   B. Market Analytics.....II-85
Table 28: US Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-85
1$350
   Table 29: US Historic Review for Cardiac Rhythm Management Devices by Product Segment - ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-861$350
   Table 30: US 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-871$350
   A. Market Analysis.....II-88
Outlook.....II-88
Major Market Trends.....II-88
Flourishing Market for CRM Market in Western Europe.....II-88
Bright Future for CRM Devices Industry.....II-88
1$100
   Highly Competitive External Defibrillators Market Paves Way for
  Consolidations.....II-89
Strong Demand for Implantable Cardiac Defibrillators in UK.....II-89
1$100
   B. Market Analytics.....II-90
Table 31: European Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-90
1$350
   Table 32: European Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-911$350
   Table 33: European 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-921$350
   A. Market Analysis.....II-93
Outlook.....II-93
Major Market Trends.....II-93
Increasing Heart Diseases Spur Demand for CRM Devices.....II-93
Chinese CRM Market to Witness Robust Growth.....II-93
1$100
   B. Market Analytics.....II-94
Table 34: Asia Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-94
1$350
   Table 35: Asia Pacific Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-951$350
   Table 36: Asia Pacific 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-961$350
   A. Market Analysis.....II-97
Outlook.....II-97
Market Share Statistics.....II-97
Table 37: ImplanTable Cardioverter Defibrillator (ICD) Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St Jude Medical, and Others (includes corresponding Graph/Chart).....II-97

Table 38: Core Pacemakers & CRT-P Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, St. Jude, Boston Scientific and Others (includes corresponding Graph/Chart).....II-97
1$350
   B. Market Analytics.....II-98
Table 39: Rest of World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-98
1$350
   Table 40: Rest of World Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-991$350
   Table 41: Rest of World 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-1001$350
  
Total Companies Profiled: 48 (including Divisions/Subsidiaries - 125)

Region/Country Players

The United States 30 Canada 7 Japan 8 Europe 67 France 8 Germany 13 The United Kingdom 8 Italy 7 Spain 5 Rest of Europe 26 Asia-Pacific (Excluding Japan) 10 Latin America 2 Africa 1
Click here to request a full table of contents and more details on this project.